Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate

By Fukasawa L.O.   Gorla M.C.O.   Schenkman R.P.F.   Garcia L.R.   Carneiro S.M.   Raw I.   Tanizaki M.M.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2951-2958

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile

By Hoppenbrouwers K.   Lagos R.   Swennen B.   Ethevenaux C.   Knops J.   Levine M.M.   Desmyter J.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 921-927

Elsevier

Access to resources Recommend Favorite

Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey

By Hoppenbrouwers K.   Kanra G.   Roelants M.   Ceyhan M.   Vandermeulen C.   Yurdako   k K.   Silier T.   Dupuy M.   Pehlivan T.   O   zmert E.   Desmyter J.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 875-886

Elsevier

Access to resources Recommend Favorite

Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease

By Fischer M.   Carlone G.M.   Holst J.   Williams D.   Stephens D.S.   Perkins B.A.  

Vaccine, Vol. 17, Iss. 19, 1999-05 ,pp. : 2377-2383

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 g liquid formulation: a comparison of three lots with the 15.0 g lyophilized formulation

By Study Group for 7.5  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 775-781

Elsevier

Access to resources Recommend Favorite